The antiviral COVID medication molnupiravir made by Merck can cause mutations in the coronavirus that occasionally spread to other people, according to a study published in the online journal Nature. There’s no evidence that molnupiravir has caused the creation of more transmissible or severe variants of COVID.
Sept. 25, 2023 -- The antiviral COVID medication made by Merck can cause mutations in the coronavirus that occasionally spread to other people, according to a study published in the online journalThere’s no evidence that molnupiravir, sold under the brand name Lagevrio, has caused the creation of more transmissible or severe variants of COVID, the study says, but researchers called for more scrutiny of the drug.
Molnupiravir is an antiviral given to people after they show signs of having COVID-19. It interferes with the COVID-19 virus’s ability to make copies of itself, thus stopping the spread of the virus throughout the body and keeping the virus level low. Theo Sanderson, the lead author on the study and a postdoctoral researcher at the Francis Crick Institute in London, told“The signature is very clear, but there aren’t any widely circulating variants that have the signature. At the moment there’s nothing that’s transmitted very widely that’s due to molnupiravir,” he said.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Merck’s COVID antiviral may be linked to virus mutations, study findsMolnupiravir, which was granted an emergency use authorization by the FDA in December 2021, may allow mutated viruses to spread, a study has found.
Weiterlesen »
Antiviral Med Linked to COVID Mutations That Can SpreadResearchers looked at 15 million COVID genomes and discovered that hallmark mutations linked to molnupiravir increased in 2022.
Weiterlesen »
Unintended Side Effect: Antiviral Drug Linked to Unusual COVID-19 Virus MutationsA study found a connection between the antiviral drug molnupiravir and distinct SARS-CoV-2 mutations, emphasizing the need for careful assessment in drug development. Researchers at the Francis Crick Institute, the University of Cambridge, Imperial College London, the University of Liverpool, the
Weiterlesen »
Merck Covid drug linked to virus mutations that can spread between people, new study saysThere is still no evidence that molnupiravir, sold under the brand name Lagevrio, has produced more transmissible or severe variants of Covid.
Weiterlesen »
A blood test for long COVID is possible, a study suggestsMore than three years into the pandemic, the millions of people who have suffered from long COVID finally have scientific proof that their condition is real.
Weiterlesen »